Genomics company explores NFTs in hopes of advancing precision medicine
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
GeneNFTs may be a game-changer for genomic testing, but user education is still needed in order for this model to advance.
Why this matters
This nft story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Robinhood Explores Stock Token Tied to T. Rowe Price Actively Managed ETF
Robinhood Crypto said in a post on Thursday that it is exploring a Stock Token tied to an actively managed ETF, with T. Rowe Price...
Cardano Foundation spins out Veridian as an independent digital identity company
Veridian's independence could accelerate digital identity innovation, impacting global security, privacy standards, and blockchain...
Europol Urges Crypto Wallet Providers to Start Testing Post-Quantum Upgrades Now
Europol published two reports on Wednesday about the security risks of quantum computing, and the one on cryptocurrencies names wa...
Blockchain and digital asset news outlet Cointelegraph explores sale: Report
Cointelegraph's traffic collapse highlights the risks of SEO penalties, impacting brand value and posing challenges for potential...
Polymarket explores an onchain asset with programmable utility, but no token yet
Polymarket's exploration of onchain assets with programmable utility could redefine digital asset functionality and influence futu...
Franklin Templeton Explores SEC Relief for Tokenized Fund Trades
Franklin Templeton is exploring whether regulatory exemptions could allow tokenized money market funds and ETFs to trade through b...